US pharmaceutical giant Pfizer Inc's India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to pose a risk to humans. Corex is a combination of chlopheniramine maleate and codeine syrup, one of 344 drug combinations India banned over the weekend after a government panel of experts found they had 'no therapeutic justification'.Read more from our special coverage on "PFIZER"Pfizer to get patent for cholesterol lowering formulation All these medicines have entered the market over the years based on ...
Pfizer stops selling popular Corex cough syrup in India after ban
India has banned over 344 drug combinations after a govt panel of experts found that they had no therapeutic justification
Topics
Pfizer
Reuters |
First Published: Mon, March 14 2016. 09:56 IST
This article is no longer available in our repository.
There could be multiple reasons for this.
You could try searching for this headline on the source website (reuters.com).